Hello, you are using an old browser that's unsafe and no longer supported. Please consider updating your browser to a newer version, or downloading a modern browser.
Hello, you are using an old browser that's unsafe and no longer supported. Please consider updating your browser to a newer version, or downloading a modern browser.
We remain committed to business continuity while protecting the health and well-being of our employees and their families, our patients and clients.
Learn More about our COVID-19 pandemic responsePartnering with the biopharmaceutical industry to provide leading late stage and patient support services focused on patient safety, access, and value.
Developing a drug, taking it through commercialization, and demonstrating its post-launch value and safety is a complex journey. Our diverse suite of services help bridge the gap between development and delivery by focusing on making medicine and medical products safer and more accessible to patients.
Learn MoreReal Data
Real People
Real Outcomes
Our customizable and innovative tools enhance UBC’s Global Late Stage, Safety, and Patient Support Services focusing on patient safety, data security, efficiency, quality, and product value.
Learn More
Article | Tuesday, May 19, 2020
Pharmaceutical and biotech companies benefit from working with external partners to manage pharmacovigilance activities. The breadth and scope of required services can depend on the mix of investigational and marketed products, the size of the company, and their comfort with outsourcing safety. Organizations realize a variety of benefits when collaborating with an external partner for safety services.
Read More
Article | Tuesday, May 19, 2020
UBC’s Dr. Annette Stemhagen received well-deserved recognition at this year’s DIA Global Annual Meeting with an Excellence in Service Inspire Award.
Read More
Article | Tuesday, May 19, 2020
During the 12th REMS Summit in Virginia, UBC’s Natalie O’Donnell, Corporate Vice President, Safety, REMS, and Strategic Engagement and Justin Wilson, Director, Software Development and Technology, presented a session on the impact technology has had on REMS and the potential effect it can have in the future. They discussed how technology has become transformative, reducing patient and health care professional burden and improving compliance with REMS requirements.
Read MoreIf you are with a pharmaceutical or biotech company and seeking information on UBC services, please fill out the form below. For all other general inquires please message: contact@ubc.com
* required field
If you are with a pharmaceutical or biotech company and seeking information on UBC services, please fill out the form below.For all other general inquires please message: contact@ubc.com
* required field
